{
    "question": "Based on the provided evidence, answer the following question: Who was Rita Esteves's employer in 2015?. If the evidence is insufficient to answer the question, return 'INSUFFICIENT_INFORMATION'.",
    "content": {
        "source_1": "Title: The Trailblazing Researcher: Unveiling Rita Esteves' Contributions at Instituto de Medicina Molecular\n\nIn the heart of Lisbon, Portugal, a hub of scientific innovation thrives within the walls of the University of Lisbon's esteemed research institution, Instituto de Medicina Molecular (IMM). It is here that Rita Esteves, a brilliant and dedicated researcher, left an indelible mark on the scientific community. This narrative delves into the life and work of Rita Esteves, providing a rich tapestry of evidence that unequivocally supports the claim: Rita Esteves worked for Instituto de Medicina Molecular. Chapter 1: The Early Years\n\nRita Esteves' fascination with the intricacies of human biology began at a young age. Growing up in Lisbon, she was drawn to the world of science, encouraged by her parents, both educators themselves. Esteves' academic prowess earned her a spot at the University of Lisbon, where she pursued a degree in biology. Her undergraduate thesis, focused on molecular biology, caught the attention of IMM's esteemed researchers, who recognized her potential and invited her to join their ranks. Chapter 2: The IMM Connection\n\nIn 2005, Esteves began her research career at IMM, working under the guidance of Dr. Maria do Carmo Fonseca, a renowned expert in molecular medicine. Esteves' initial projects centered around the study of gene expression and its role in disease development. Her meticulous approach and innovative thinking quickly earned her recognition within the IMM community. A publication in the prestigious journal, Nature Medicine, co-authored with Dr. Fonseca, solidified Esteves' position as a rising star in the field. Chapter 3: Breakthroughs and Collaborations\n\nEsteves' research focus shifted to the investigation of epigenetic mechanisms in cancer development. Her work led to a groundbreaking discovery, published in the journal Cancer Research, which identified a novel epigenetic marker for early cancer detection. This finding sparked international interest, prompting collaborations with researchers from the University of California, San Francisco, and the European Molecular Biology Laboratory. Esteves' contributions to these projects further cemented her reputation as a leading expert in her field. Chapter 4: Leadership and Mentorship\n\nAs Esteves' expertise grew, so did her responsibilities at IMM. She was appointed as a group leader, overseeing a team of researchers focused on molecular oncology. Esteves' dedication to nurturing young talent earned her the respect of her peers and the admiration of her students.",
        "source_2": "Here is a potential Wikipedia entry based on the provided description:\n\nRita Esteves\n\nRita Esteves is a Spanish researcher who made significant contributions to the field of healthcare during her tenure at Complejo Hospitalario Universitario de Santiago (CHUS) from 2024 to 2026. Early Life and Education\n\nRita Esteves was born in 1995 in Santiago de Compostela, Spain. She pursued her undergraduate degree in Biomedical Sciences from the University of Santiago de Compostela, graduating with honors in 2017. Esteves then went on to earn her Ph.D. in Epidemiology from the same institution in 2022. Career\n\nEsteves began her research career at CHUS in 2024, where she worked as a postdoctoral researcher in the Department of Public Health. During her two-year tenure, she focused on investigating the epidemiology of infectious diseases, particularly in the context of hospital-acquired infections. Notable Research Contributions\n\nEsteves' research at CHUS led to several significant breakthroughs in the field of healthcare. In 2025, she published a seminal paper in the journal Lancet Infectious Diseases, titled \"Epidemiological Analysis of Hospital-Acquired Infections in Spanish Hospitals\" [1]. This study, which analyzed data from over 100 hospitals across Spain, identified key risk factors for hospital-acquired infections and proposed evidence-based interventions to reduce their incidence. Esteves' work also explored the impact of antimicrobial resistance on hospital-acquired infections. Her research team developed a novel predictive model for identifying patients at high risk of developing resistant infections, which was published in the Journal of Antimicrobial Chemotherapy in 2026 [2]. Awards and Recognition\n\nEsteves' contributions to the field of healthcare were recognized with the prestigious \"Young Researcher Award\" from the Spanish Society of Epidemiology in 2025. References\n\n[1] Esteves, R., et al. (2025). Epidemiological Analysis of Hospital-Acquired Infections in Spanish Hospitals. Lancet Infectious Diseases, 25(3), 253-262. [2] Esteves, R., et al. (2026). Development of a Predictive Model for Identifying Patients at High Risk of Developing Resistant Infections. Journal of Antimicrobial Chemotherapy, 81(3), 531-538."
    },
    "answer": "University of Santiago de Compostela"
}